Goa Medicos Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.00 Cr
as on 16-11-2024
- Company Age 28 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 46.91 Cr
as on 16-11-2024
- Satisfied Charges ₹ 7.10 Cr
as on 16-11-2024
- Revenue -14.53%
(FY 2023)
- Profit -32.90%
(FY 2023)
- Ebitda -29.87%
(FY 2023)
- Net Worth 41.53%
(FY 2023)
- Total Assets 19.15%
(FY 2023)
About Goa Medicos
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹46.91 Cr. The company has closed loans amounting to ₹7.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kiran Syal, Vinod Syal, Sunny Syal, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397DL1996PTC081819
- Company No.
081819
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Goa Medicos?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunny Syal  | Director | 27-May-2009 | Current |
| Kiran Syal | Director | 11-Sep-1996 | Current |
| Vinod Syal | Director | 11-Sep-1996 | Current |
| Priyanka Syal | Director | 12-Sep-2019 | Current |
Financial Performance of Goa Medicos.
Goa Medicos Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.53% decrease. The company also saw a substantial fall in profitability, with a 32.9% decrease in profit. The company's net worth Soared by an impressive increase of 41.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Goa Medicos?
In 2023, Goa Medicos had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 May 2022 | ₹20.00 Cr | Open |
Others Creation Date: 20 Dec 2021 | ₹26.91 Cr | Open |
Others Creation Date: 29 Dec 2015 | ₹4.90 Cr | Satisfied |
How Many Employees Work at Goa Medicos?
Goa Medicos has a workforce of 158 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goa Medicos, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goa Medicos's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
